Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Back In As Of Today

<< Previous

Bullboard Posts

Next >>

Comment by newcoinon Aug 20, 2023 10:20am

202 Views

Post# 35596875

RE:RE:RE:RE:RE:Back In As Of Today

We are now in the middle of the summer doldrums I referred to in this previous post. A share price under three dollars is a gift. I hope everyone is accumulating as I am doing. Shares won't get any cheaper in the next few months.

newcoin wrote: Good to be back, westcoast1000.
My re entry is not without reservation. Let's face it - 25 years now?! Many hearts have been broken.
There does appear to be a preponderance of evidence to suggest this is a fabulous time to own ONC.
Summer doldrums do often set in and if they do again this year it will provide an even better opportunity. I'll have a full position by the end of August.
Very excited to be back!!

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?